EyePoint Pharmaceuticals
EYPT
#5171
Rank
A$2.28 B
Marketcap
A$27.64
Share price
3.27%
Change (1 day)
99.88%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$77.71 Million

According to EyePoint Pharmaceuticals 's latest financial reports the company's total liabilities are A$77.71 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

EyePoint Pharmaceuticals - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.13 B1.03%
2023-12-31A$0.13 B5.68%
2022-12-31A$0.12 B13.27%
2021-12-31A$0.10 B14.49%
2020-12-31A$95.16 M3.08%
2019-12-31A$92.32 M
2018-06-30A$81.02 M1064.73%
2017-06-30A$6.95 M-51.74%
2016-06-30A$14.41 M23.25%
2015-06-30A$11.69 M42.36%
2014-06-30A$8.21 M-12.27%
2013-06-30A$9.36 M37.79%
2012-06-30A$6.79 M-24.75%
2011-06-30A$9.03 M-23.29%
2010-06-30A$11.77 M-29.77%
2009-06-30A$16.76 M-37.62%
2008-06-30A$26.87 M20.06%
2007-06-30A$22.38 M-63.11%
2006-06-30A$60.68 M401.01%
2005-06-30A$12.11 M521.12%
2004-06-30A$1.95 M121.34%
2003-06-30A$0.88 M
2001-06-30A$0.28 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
A$0.18 B 135.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
A$4.74 M-93.89% Bahamas